I think this is one of the best penny stocks yet in IPO after all the huge ipos... it is a HIGH RISK-HIGHER RETURN... expect it to list above 15 and hit intraday high of 20++... recommended ONLY for short term investors... NOT FOR Long term investors... INVEST A LOT IN THIS IPO....
PLEASE TELL ME THE PROMOTER'S HOLDINGS OF SAAMYA BIOTECH, ALSO ADVICE TO APPLY FOR IPO OR NOT FOR SHORT TERM & HOW MUCH IS THE LISTING PRICE EXPECTED FOR THIS SHARE.
I think this is an excellent stock in terms of listing gains. 80-90% return for sure. If you are a long term investor then you can avoid, otherwise I would recommend subscribe!
Can give huge returns..............Be optimistic 1000 shares at 10000 bucks....even if it opens at 7-6 bucks just 3-4 thousand loss........ Opposite also possible....................
ICRA rating for Saamya IPO is 1, meaning poor fundamentals.
Promoters earlier floated Maanya Biotech, and wanted to bring public offer for that company, but "could not do so". The reasons given in RHP are indicative of the class of promoters.
The company has not started manufacturing yet. AVOID.